SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCoats Group Plc Regulatory News (COA)

Share Price Information for Coats Group Plc (COA)

Share Price is delayed by 15 minutes
Get Live Data
79.95    1.45 (1.85%)
Bid:
79.45
Ask:
79.60
Spread: 0.15 (0.189%)
Market Cap: £1.53b
COA Live PriceLast checked at - London Stock Exchange

Intraday Coats Group Plc Share Chart

Trading Statement

19 May 2021 07:00

RNS Number : 0607Z
Coats Group PLC
19 May 2021
Β 

19 May 2021

Coats Group plc

Trading update

Β 

Coats Group plc ('Coats', the 'Company' or the 'Group'), the world's leading industrial thread manufacturer, today announces a trading update for the period 1 January 2021 to 30 April 2021 ('the period'), ahead of its Annual General Meeting later today. Given the exceptional circumstances of 2020, we include 2019 detail in this statement.

Β 

Trading Update

Β· Strong operational performance and a return to organic growth vs 2019

Β· Pricing and productivity actions being successfully implemented to offset inflationary pressures

Β· Performance for the year anticipated to be slightly ahead of our previous expectations

Β 

Revenue vs 2020

Revenue vs 2019

Reported

CER1

Organic2

Reported

CER1

Organic3

Group

28%

27%

26%

3%

5%

1%

Apparel & Footwear

31%

30%

30%

(2)%

0%

0%

Performance Materials

18%

18%

14%

22%

24%

4%

Β 

All following references are on an organic CER basis.

Β 

Organic group sales for the period grew 26% year-on-year (1% versus 2019).

Β 

In Apparel and Footwear we saw improving momentum and recovery (up 30% versus 2020 and flat versus 2019). Robust volume growth resulted in increased factory activity. Against 2019 the core thread business (which represents c.85% of Apparel and Footwear) grew solidly (up 2%). Key markets performed well vs 2019, albeit zips are recovering at a slower pace.

Β 

Performance Materials was up 14% versus 2020 and 4% versus 2019, with all segments performing well and growing against 2019 and 2020, with the exception of Personal Protection. Personal Protection continues to be impacted by labour availability issues, specifically in the US Yarns business.

Β 

Pricing and productivity actions are being successfully implemented to offset inflationary pressures (raw materials, labour and freight inflation) in the supply chain.

Β 

In April we announced the completion of a three year $360 million ESG-linked bank refinancing (with the ability for two one-year extensions). Our committed debt facilities total $585 million across our Banking and US Private Placement group, with a range of maturities from 2024 through to 2027, and we currently have around $350 million of committed headroom against these banking facilities. As at 30 April 2021 our net debt (excluding IFRS16) was $162 million (31 December 2020 $181 million).

Β 

Rajiv Sharma, Chief Executive, commented:

"We are pleased to have seen recovery and positive momentum during the period, which resulted in a strong operational performance and a return to growth vs 2019. Whilst we remain vigilant around the ongoing Covid pandemic, given the improving end market sentiment, we anticipate that the recovery in our trading will continue and that our anticipated performance for the year will be slightly ahead of our previous expectations.

Β 

During the period we continued to implement self-help programs related to price and productivity. We also maintained focus on our strategic pillars of Digital, Innovation and Sustainability, which are a source of competitive advantage today and into the future. A strong balance sheet provides strategic optionality and positions us well to continue to win the recovery."

Β 

1

Constant Exchange Rate (CER) are 2020 and 2019 results restated at 2021 exchange rates;

2

Organic on a CER basis includes like-for-like contributions from Pharr HP (post acquisition date of February 2020);

3

Organic on a CER basis includes like-for-like contributions from Threadsol (post acquisition date of February 2019) and excludes contribution from Pharr HP (acquired in February 2020)

_________________________________________________________________________________________

Β 

Enquiry details

Investors

Victoria Huxster

Coats Group plc

+44 (0)7880 471 350

Media

Richard Mountain / Nick Hasell

FTI Consulting

+44 (0)20 3727 1374

_________________________________________________________________________________________

Β 

About Coats Group plc

Coats is the world's leading industrial thread company. At home in some 50 countries, Coats has a workforce of 17,000 people across six continents. Revenues in 2020 were US$1.2bn. Coats' pioneering history and innovative culture ensure the company leads the way around the world. It provides complementary and value added products, services and software solutions to the apparel and footwear industries. It applies innovative techniques to develop high technology Performance Materials threads, yarns and fabrics in areas such as Transportation, Telecommunications and Energy, and Personal Protection. Headquartered in the UK, Coats is a FTSE 250 company, a constituent of the FTSE4Good Index Series, a participant in the UN Global Compact and a member of the Ellen MacArthur Foundation. It has also committed to developing a long-term target to reach net-zero emissions by 2050, the highest level of ambition on climate under the Science Based Target Initiative.

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
TSTDKFBBCBKDQPD
Date   Source Headline
4th Mar 20217:00 amRNS2020 Full Year Results
3rd Mar 20217:00 amRNSRemuneration and Audit Committee Changes
26th Feb 202110:52 amRNSTotal Voting Rights
2nd Feb 202111:30 amRNSHolding(s) in Company
28th Jan 202111:07 amRNSHolding(s) in Company
31st Dec 20201:31 pmRNSTotal Voting Rights
23rd Dec 20207:00 amRNSDirector/PDMR Shareholding
1st Dec 20204:05 pmRNSDirector/PDMR Shareholding
26th Nov 202011:11 amRNSDirector/PDMR Shareholding
24th Nov 20207:00 amRNSNew Chairman appointment
23rd Nov 20202:29 pmRNSHolding(s) in Company
5th Nov 202012:36 pmRNSHolding(s) in Company
3rd Nov 20207:00 amRNSTrading Statement
14th Oct 20207:00 amRNSConfirmation of CFO Designate start date
6th Oct 202011:09 amRNSBlock listing Interim Review
22nd Sep 20207:00 amRNSDirector Declaration
13th Aug 20207:00 amRNSHalf-year Report
29th Jul 20207:00 amRNSAppointment of Chief Financial Officer Designate
29th Jun 20209:25 amRNSHolding(s) in Company
11th Jun 20203:17 pmRNSResult of AGM
27th May 20204:47 pmRNSDirector/PDMR Shareholding
20th May 20207:00 amRNSTrading Statement
18th May 20202:28 pmRNSNotice of AGM
18th May 202010:03 amRNSDirectorate Change
13th May 20203:06 pmRNSNotice of AGM
28th Apr 20205:24 pmRNSHolding(s) in Company
28th Apr 20201:21 pmRNSNotice of AGM
27th Apr 20202:01 pmRNSDisclosure of rights attached to securities
23rd Apr 20201:48 pmRNSHolding(s) in Company
3rd Apr 20202:13 pmRNSBlock listing Interim Review
2nd Apr 20204:30 pmRNSHolding(s) in Company
1st Apr 20207:00 amRNSDirectorate Change
27th Mar 20207:00 amRNSTrading Statement
24th Mar 20204:19 pmRNSHolding(s) in Company
23rd Mar 20209:48 amRNSHolding(s) in Company
20th Mar 20204:45 pmRNSSecond Price Monitoring Extn
20th Mar 20204:36 pmRNSPrice Monitoring Extension
12th Mar 20202:52 pmRNSDirector/PDMR Shareholding
12th Mar 202010:46 amRNSDirector/PDMR Shareholding
11th Mar 202010:14 amRNSHolding(s) in Company
10th Mar 20201:31 pmRNSAnnual Financial Report
9th Mar 20208:13 amRNSDirector/PDMR Shareholding
6th Mar 20202:18 pmRNSDirector/PDMR Shareholding
6th Mar 20202:17 pmRNSDirector/PDMR Shareholding
6th Mar 20208:23 amRNSHolding(s) in Company
5th Mar 20207:00 amRNSFinal Results
2nd Mar 202011:03 amRNSAdditional Listing
28th Feb 20203:48 pmRNSTotal Voting Rights
14th Feb 20201:29 pmRNSHolding(s) in Company
11th Feb 20207:00 amRNSAcquisition

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.